Supporting the goals of Overdose Awareness Day by lowering the United States flag to half-staff on all Federal buildings the 31st day of August each year.
- Last Action
- 4/22/2021
Actions
- 2021-02-05Sponsor introductory remarks on measure. (CR H393)
- 2021-02-02Referred to the Subcommittee on Health.
- 2021-01-19Referred to the House Committee on Energy and Commerce.
- 2021-01-19Introduced in House
- 2021-01-19Introduced in House
CRS Summary
As of 2021-01-19 (00)
Coronavirus Vaccine and Therapeutic Development Act of 2021
This bill directs the Department of Health and Human Services (HHS) to increase the supply of vaccines and medical products that prevent or control COVID-19 (i.e., coronavirus disease 2019). To increase supplies, HHS must, as appropriate, award grants and enter other transactions to expand relevant research, procurement, and production activities.
HHS must report to Congress on these actions. The report must assess and detail plans to enhance the supply chain and manufacturing capacity for the vaccines and products. It must also include plans to support domestic and international vaccination programs.
Cosponsors (11)
- Hakeem Jeffries (D-NY)
- Nikema Williams (D-GA)
- Julia Brownley (D-CA)
- Lisa Blunt Rochester (D-DE)
- Lori Trahan (D-MA)
- Marilyn Strickland (D-WA)
- Kim Schrier (D-WA)
- Lois Frankel (D-FL)
- Terri Sewell (D-AL)
- Derek Kilmer (D-WA)
- Val Demings (D-FL)
Subjects
- Cardiovascular and respiratory health
- Congressional oversight
- Emergency medical services and trauma care
- Health promotion and preventive care
- Health technology, devices, supplies
- Immunology and vaccination
- Infectious and parasitic diseases
- Manufacturing
- Public contracts and procurement
- Research and development
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.